Daiwa Securities Group Inc. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 129 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$03720.0%0.00%
Q2 2022$0
-100.0%
3720.0%0.00%
Q1 2022$1,0000.0%3720.0%0.00%
Q4 2021$1,0000.0%3720.0%0.00%
Q3 2021$1,000
-50.0%
3720.0%0.00%
Q2 2021$2,000
+100.0%
3720.0%0.00%
Q1 2021$1,0000.0%3720.0%0.00%
Q4 2020$1,000
-50.0%
372
-54.1%
0.00%
Q3 2020$2,000
+100.0%
8100.0%0.00%
Q2 2020$1,0000.0%8100.0%0.00%
Q1 2020$1,000
-50.0%
8100.0%0.00%
Q4 2019$2,0000.0%8100.0%0.00%
Q3 2019$2,0000.0%8100.0%0.00%
Q2 2019$2,0000.0%8100.0%0.00%
Q1 2019$2,0000.0%8100.0%0.00%
Q4 2018$2,000
-33.3%
8100.0%0.00%
Q3 2018$3,000
+50.0%
8100.0%0.00%
Q2 2018$2,000
-33.3%
8100.0%0.00%
Q1 2018$3,0008100.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders